Harbor Capital Advisors’s Cellebrite CLBT Stock Holding History

Harbor Capital Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Sell	118,178 -868	-0.7%	-$11.5K	0.12%	251
2026 Q1	$1.64M	Buy	119,046 +631	+0.5%	+$9.51K	0.13%	234
2025 Q4	$2.13M	Sell	118,415 -2,491	-2%	-$44.7K	0.17%	160
2025 Q3	$2.24M	Sell	120,906 -24,786	-17%	-$389K	0.17%	157
2025 Q2	$2.33M	Buy	145,692 +23,638	+19%	+$421K	0.1%	268
2025 Q1	$2.37M	Sell	122,054 -35,617	-23%	-$750K	0.11%	257
2024 Q4	$3.47M	Buy	157,671 +62,320	+65%	+$1.2M	0.15%	198
2024 Q3	$1.61M	Buy	95,351 +46,727	+96%	+$693K	0.07%	366
2024 Q2	$581K	Buy	48,624 +36,808	+312%	+$411K	0.04%	494
2024 Q1	$131K	Buy	+11,816	New	+$121K	0.02%	687

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Central Securities New York $1.34B AUM 21.03% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UIM

USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

Harbor Capital Advisors's CLBT Position: Q2 2026 in Review

Harbor Capital Advisors reduced its Cellebrite (CLBT) stake by 0.73% in Q2 2026, selling an estimated $11.5K and leaving 118,178 shares worth $1.73M. The position accounts for 0.12% of the portfolio, ranked #251.

Harbor Capital Advisors first reported a position in CLBT in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.47M in Q4 2024. 86 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Harbor Capital Advisors held 118,178 shares of Cellebrite worth $1.73M as of Q2 2026.
Harbor Capital Advisors sold 868 Cellebrite shares in Q2 2026, an estimated $11.5K.
Cellebrite made up 0.12% of Harbor Capital Advisors's portfolio in Q2 2026, its #251 holding.
Harbor Capital Advisors first reported a position in Cellebrite in Q1 2024 and has held it in 10 quarters since.
Harbor Capital Advisors's Cellebrite position peaked at $3.47M in Q4 2024.
86 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.